Loading…
Loading…

| MRK | Merck & Co., Inc. | $148.91 | $367.8B |
| NVS | Novartis AG | $137.83 | $262.0B |
| NVO | Novo Nordisk A/S | $45.44 | $201.8B |
| GILD | Gilead Sciences, Inc. | $146.60 | $182.0B |
| PFE | Pfizer Inc. | $27.99 | $159.5B |
| DHR | Danaher Corporation | $206.26 | $145.0B |
| BMY | Bristol-Myers Squibb Company | $65.21 | $133.2B |
| SNY | Sanofi | $43.31 | $104.0B |
| GSK | GSK plc | $48.74 | $97.7B |
| BSX | Boston Scientific Corporation | $45.36 | $67.4B |